Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.

Disease burden, serum LDH, previous liver directed, or systemic treatment did not influence hPFS on univariate analysis (Figure 4 C–F); presence of extrahepatic disease at baseline was of borderline significance for both overall PFS and hPFS ( P < 0.05 by Gehan‐Breslow‐Wilcoxon but not by log Rank test).

also in 2,624 other papers